[1]
D. Vasović, D. M. Rašić, I. Marjanović, T. Kalezić, and M. Lučić, “REVERSIBLE OCULAR ADVERSE EFFECTS IN MELANOMA TREATMENT WITH MEK/BRAF INHIBITORS”, smclk, vol. 5, no. 4, Dec. 2024, doi: 10.5937/smclk5-53696.